Journal Mobile Options

Vol. 81, Suppl. 1, 2011

Issue release date: December 2011

A Bridge to a Consensus on Hepatocellular Carcinoma Management

2nd Asia Pacific Primary Liver Cancer Expert Meeting, Osaka, July 2011

See also ISBN 978-3-8055-9927-6 for more details
Select / Unselect all
I

Title Page / Table of Contents

Oncology 2011;81(suppl 1):I–IV (DOI:10.1159/000333281)
Free Access
Introduction
1

Hepatocellular Carcinoma in 2011 and Beyond: From the Pathogenesis to Molecular Targeted Therapy

Kudo M.
Oncology 2011;81(suppl 1):1–10 (DOI:10.1159/000333252)
 
11

Hepatocarcinogenesis in Hepatitis C: HCV Shrewdly Exacerbates Oxidative Stress by Modulating both Production and Scavenging of Reactive Oxygen Species

Fujinaga H. · Tsutsumi T. · Yotsuyanagi H. · Moriya K. · Koike K.
Oncology 2011;81(suppl 1):11–17 (DOI:10.1159/000333253)
18

Signaling Pathways in Hepatocellular Carcinoma

Sia D. · Villanueva A.
Oncology 2011;81(suppl 1):18–23 (DOI:10.1159/000333254)
24

Signaling Pathways Governing Tumor Angiogenesis

Sakurai T. · Kudo M.
Oncology 2011;81(suppl 1):24–29 (DOI:10.1159/000333256)
30

Adriamycin Enhances Proteasome-Mediated Generation of the Proapoptotic Processed Form of MAGE-A4 in Hepatoma Cells

Sakurai T. · Kudo M. · Itoh K. · Ryu U. · Higashitsuji H. · Fujita J.
Oncology 2011;81(suppl 1):30–35 (DOI:10.1159/000334307)
36

Hospital- and Community-Based Screenings for Hepatocellular Carcinoma in Taiwan

Kee K.-M. · Lu S.-N.
Oncology 2011;81(suppl 1):36–40 (DOI:10.1159/000333257)
41

Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection

Kim B.K. · Han K.-H. · Ahn S.H.
Oncology 2011;81(suppl 1):41–49 (DOI:10.1159/000333258)
50

Adjuvant Therapy after Curative Treatment for Hepatocellular Carcinoma

Kudo M.
Oncology 2011;81(suppl 1):50–55 (DOI:10.1159/000333259)
56

Controversies in Surveillance and Early Diagnosis of Hepatocellular Carcinoma

Kim D.Y. · Kim J.W. · Kuromatsu R. · Ahn S.H. · Torimura T. · Sherman M.
Oncology 2011;81(suppl 1):56–60 (DOI:10.1159/000333261)
61

Highly Sensitive Lens culinaris Agglutinin-Reactive α-Fetoprotein: A New Tool for the Management of Hepatocellular Carcinoma

Toyoda H. · Kumada T. · Tada T.
Oncology 2011;81(suppl 1):61–65 (DOI:10.1159/000333263)
66

Usefulness of Combination of Imaging Modalities in the Diagnosis of Hepatocellular Carcinoma Using Sonazoid®-Enhanced Ultrasound, Gadolinium Diethylene-Triamine-Pentaacetic Acid-Enhanced Magnetic Resonance Imaging, and Contrast-Enhanced Computed Tomography

Alaboudy A. · Inoue T. · Hatanaka K. · Chung H. · Hyodo T. · Kumano S. · Murakami T. · Moustafa E.F.A. · Kudo M.
Oncology 2011;81(suppl 1):66–72 (DOI:10.1159/000333264)
73

Diagnostic Imaging of Hepatocellular Carcinoma: Recent Progress

Kudo M.
Oncology 2011;81(suppl 1):73–85 (DOI:10.1159/000333265)
86

Ultrasonography, Computed Tomography and Magnetic Resonance Imaging of Hepatocellular Carcinoma: Toward Improved Treatment Decisions

Murakami T. · Imai Y. · Okada M. · Hyodo T. · Lee W.-J. · Kim M.-J. · Kim T. · Choi B.I.
Oncology 2011;81(suppl 1):86–99 (DOI:10.1159/000333267)
100

Role of Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: Experience of a Cancer Center in China

Chen M.-S. · Peng Z.-W. · Xu L. · Zhang Y.-J. · Liang H.-H. · Li J.-Q.
Oncology 2011;81(suppl 1):100–104 (DOI:10.1159/000333268)
Retracted Paper
105

Superselective Transarterial Chemoembolization for Hepatocellular Carcinoma: Recent Progression and Perspective

Takayasu K.
Oncology 2011;81(suppl 1):105–110 (DOI:10.1159/000333269)
Free Access
 
111

Living Donor Liver Transplantation for Hepatocellular Carcinoma: The Japanese Experience

Tamura S. · Sugawara Y. · Kokudo N.
Oncology 2011;81(suppl 1):111–115 (DOI:10.1159/000333270)
116

Prognostic Indicators for Tumor Recurrence after Liver Transplantation in Hepatocellular Carcinoma and Related Molecular Targeted Therapy

Yu L. · Dai Z. · Wang Z. · Fan J. · Zhou J.
Oncology 2011;81(suppl 1):116–122 (DOI:10.1159/000333273)
123

Radiotherapeutic Strategies in the Management of Hepatocellular Carcinoma

Lee I.J. · Seong J.
Oncology 2011;81(suppl 1):123–133 (DOI:10.1159/000333275)
134

Multidisciplinary Management of Nonresectable Hepatocellular Carcinoma

Park H.C. · Seong J. · Tanaka M. · Zeng Z.-C. · Lim H.Y. · Guan S. · Bae S.H. · Tak W.Y.
Oncology 2011;81(suppl 1):134–140 (DOI:10.1159/000333276)
141

Treatment Algorithm for Intermediate and Advanced Stage Hepatocellular Carcinoma: Korea

Choi J.Y.
Oncology 2011;81(suppl 1):141–147 (DOI:10.1159/000333277)
148

Current Situation of Hepatocellular Carcinoma in Mongolia

Baatarkhuu O. · Kim D.Y. · Bat-Ireedui P. · Han K.-H.
Oncology 2011;81(suppl 1):148–151 (DOI:10.1159/000333278)
152

Complete Response of Advanced Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Sorafenib: A Case Report

Inuzuka T. · Nishikawa H. · Sekikawa A. · Takeda H. · Henmi S. · Sakamoto A. · Saito S. · Kita R. · Kimura T. · Osaki Y. · Kudo M.
Oncology 2011;81(suppl 1):152–157 (DOI:10.1159/000333279)
158

Asian Consensus Workshop Report: Expert Consensus Guideline for the Management of Intermediate and Advanced Hepatocellular Carcinoma in Asia

Han K.-H. · Kudo M. · Ye S.-L. · Choi J.Y. · Poon R.T.-P. · Seong J. · Park J.-W. · Ichida T. · Chung J.W. · Chow P. · Cheng A.-L.
Oncology 2011;81(suppl 1):158–164 (DOI:10.1159/000333280)
Further Section
165

Author Index Vol. 81, Suppl. 1, 2011

Oncology 2011;81(suppl 1):165 (DOI:10.1159/000333282)
Free Access
166

Subject Index Vol. 81, Suppl. 1, 2011

Oncology 2011;81(suppl 1):166 (DOI:10.1159/000333283)
Free Access